# 116-hr-7037: To provide for quality assurance of COVID-19 reimbursements and reporting.

116-hr-7037, To provide for quality assurance of COVID-19 reimbursements and reporting., is a 116th Congress bill sponsored by Rep. Posey, Bill [R-FL-8] (R-FL); status Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (as of 2025-11-18).

- Canonical: https://policyrisk.com/legislation/116-hr-7037
- As of: 2025-11-18
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 116-hr-7037
- Congress: 116
- Title: To provide for quality assurance of COVID-19 reimbursements and reporting.
- Status: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Introduced: 2020-05-27
- Sponsor: Rep. Posey, Bill [R-FL-8] (R-FL)
- Cosponsors: 0
- Policy area: Health
- Touches household money: no
- Last recorded action: 2025-11-18

## Summary

This bill (1) establishes documentation requirements for testing, treatment, and reporting related to COVID-19 (i.e., coronavirus disease 2019); and (2) makes it unlawful to knowingly report a false diagnosis of COVID-19. To receive a federal reimbursement for the cost of a COVID-19 diagnostic test or treatment, the request for reimbursement must document that the administered COVID-19 test has been approved, cleared, or authorized by the Food and Drug Administration. Further, the Centers for Disease Control and Prevention must exclude from its official COVID-19 case and death counts any person who tested positive and requested federal reimbursement without the required documentation. Additionally, any person who knowingly reports a false diagnosis of COVID-19 is subject to criminal fines and imprisonment for not more than 10 years.

## Related bills

- 116-hr-8991: American Election Security Act
- 116-hr-8830: You Must Be Alive To Vote Act of 2020
- 116-hr-8757: BRICKS Act of 2020
- 116-hr-8702: Holding Providers Harmless From Medicare Cuts During COVID–19 Act of 2020
- 116-hr-8675: Preventing Regulatory Penalties for PPP Lenders Act
- 116-hr-8662: Accelerating Access to Critical Therapies for ALS Act

## Sources
- [116-hr-7037 on Congress.gov](https://www.congress.gov/bill/116th-congress/house-bill/7037)

## Related
- [116-hr-8991: American Election Security Act](https://policyrisk.com/legislation/116-hr-8991)
- [116-hr-8830: You Must Be Alive To Vote Act of 2020](https://policyrisk.com/legislation/116-hr-8830)
- [116-hr-8757: BRICKS Act of 2020](https://policyrisk.com/legislation/116-hr-8757)
- [116-hr-8702: Holding Providers Harmless From Medicare Cuts During COVID–19 Act of 2020](https://policyrisk.com/legislation/116-hr-8702)
- [116-hr-8675: Preventing Regulatory Penalties for PPP Lenders Act](https://policyrisk.com/legislation/116-hr-8675)
- [116-hr-8662: Accelerating Access to Critical Therapies for ALS Act](https://policyrisk.com/legislation/116-hr-8662)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/116-hr-7037 (as of 2025-11-18).